Industry: Food & Beverages
Published Date: 2025-03-13
Pages: 166 Pages
Report ld: 4660326
Request Sample
Customized Report
Stage 2 Infant Formula Market Size(US$)

CAGR 2025-2031
6.7%
Market Size,2031
USD 32,040
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Stage 2 Infant Formula was estimated to be worth US$ 20480 million in 2024 and is forecast to a readjusted size of US$ 32040 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
North American market for Stage 2 Infant Formula was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Stage 2 Infant Formula was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Stage 2 Infant Formula was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Stage 2 Infant Formula include Mead Johnson, Nestle, Danone, Abbott, FrieslandCampina, Heinz, Bellamy, Topfer, HiPP, Perrigo, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Stage 2 Infant Formula, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Stage 2 Infant Formula by region & country, by Type, and by Application.
The Stage 2 Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stage 2 Infant Formula.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Stage 2 Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Stage 2 Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Stage 2 Infant Formula in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Stage 2 Infant Formula Product Introduction
1.2 Global Stage 2 Infant Formula Market Size Forecast
1.2.1 Global Stage 2 Infant Formula Sales Value (2020-2031)
1.2.2 Global Stage 2 Infant Formula Sales Volume (2020-2031)
1.2.3 Global Stage 2 Infant Formula Sales Price (2020-2031)
1.3 Stage 2 Infant Formula Market Trends & Drivers
1.3.1 Stage 2 Infant Formula Industry Trends
1.3.2 Stage 2 Infant Formula Market Drivers & Opportunity
1.3.3 Stage 2 Infant Formula Market Challenges
1.3.4 Stage 2 Infant Formula Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Stage 2 Infant Formula Players Revenue Ranking (2024)
2.2 Global Stage 2 Infant Formula Revenue by Company (2020-2025)
2.3 Global Stage 2 Infant Formula Players Sales Volume Ranking (2024)
2.4 Global Stage 2 Infant Formula Sales Volume by Company Players (2020-2025)
2.5 Global Stage 2 Infant Formula Average Price by Company (2020-2025)
2.6 Key Manufacturers Stage 2 Infant Formula Manufacturing Base and Headquarters
2.7 Key Manufacturers Stage 2 Infant Formula Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Stage 2 Infant Formula
2.9 Stage 2 Infant Formula Market Competitive Analysis
2.9.1 Stage 2 Infant Formula Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Stage 2 Infant Formula Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stage 2 Infant Formula as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Conventional
3.1.2 Organic
3.2 Global Stage 2 Infant Formula Sales Value by Type
3.2.1 Global Stage 2 Infant Formula Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Stage 2 Infant Formula Sales Value, by Type (2020-2031)
3.2.3 Global Stage 2 Infant Formula Sales Value, by Type (%) (2020-2031)
3.3 Global Stage 2 Infant Formula Sales Volume by Type
3.3.1 Global Stage 2 Infant Formula Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Stage 2 Infant Formula Sales Volume, by Type (2020-2031)
3.3.3 Global Stage 2 Infant Formula Sales Volume, by Type (%) (2020-2031)
3.4 Global Stage 2 Infant Formula Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Online Sales
4.1.2 Offline Sales
4.2 Global Stage 2 Infant Formula Sales Value by Application
4.2.1 Global Stage 2 Infant Formula Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Stage 2 Infant Formula Sales Value, by Application (2020-2031)
4.2.3 Global Stage 2 Infant Formula Sales Value, by Application (%) (2020-2031)
4.3 Global Stage 2 Infant Formula Sales Volume by Application
4.3.1 Global Stage 2 Infant Formula Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Stage 2 Infant Formula Sales Volume, by Application (2020-2031)
4.3.3 Global Stage 2 Infant Formula Sales Volume, by Application (%) (2020-2031)
4.4 Global Stage 2 Infant Formula Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Stage 2 Infant Formula Sales Value by Region
5.1.1 Global Stage 2 Infant Formula Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Stage 2 Infant Formula Sales Value by Region (2020-2025)
5.1.3 Global Stage 2 Infant Formula Sales Value by Region (2026-2031)
5.1.4 Global Stage 2 Infant Formula Sales Value by Region (%), (2020-2031)
5.2 Global Stage 2 Infant Formula Sales Volume by Region
5.2.1 Global Stage 2 Infant Formula Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Stage 2 Infant Formula Sales Volume by Region (2020-2025)
5.2.3 Global Stage 2 Infant Formula Sales Volume by Region (2026-2031)
5.2.4 Global Stage 2 Infant Formula Sales Volume by Region (%), (2020-2031)
5.3 Global Stage 2 Infant Formula Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Stage 2 Infant Formula Sales Value, 2020-2031
5.4.2 North America Stage 2 Infant Formula Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Stage 2 Infant Formula Sales Value, 2020-2031
5.5.2 Europe Stage 2 Infant Formula Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Stage 2 Infant Formula Sales Value, 2020-2031
5.6.2 Asia Pacific Stage 2 Infant Formula Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Stage 2 Infant Formula Sales Value, 2020-2031
5.7.2 South America Stage 2 Infant Formula Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Stage 2 Infant Formula Sales Value, 2020-2031
5.8.2 Middle East & Africa Stage 2 Infant Formula Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Stage 2 Infant Formula Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Stage 2 Infant Formula Sales Value and Sales Volume
6.2.1 Key Countries/Regions Stage 2 Infant Formula Sales Value, 2020-2031
6.2.2 Key Countries/Regions Stage 2 Infant Formula Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Stage 2 Infant Formula Sales Value, 2020-2031
6.3.2 United States Stage 2 Infant Formula Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Stage 2 Infant Formula Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Stage 2 Infant Formula Sales Value, 2020-2031
6.4.2 Europe Stage 2 Infant Formula Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Stage 2 Infant Formula Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Stage 2 Infant Formula Sales Value, 2020-2031
6.5.2 China Stage 2 Infant Formula Sales Value by Type (%), 2024 VS 2031
6.5.3 China Stage 2 Infant Formula Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Stage 2 Infant Formula Sales Value, 2020-2031
6.6.2 Japan Stage 2 Infant Formula Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Stage 2 Infant Formula Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Stage 2 Infant Formula Sales Value, 2020-2031
6.7.2 South Korea Stage 2 Infant Formula Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Stage 2 Infant Formula Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Stage 2 Infant Formula Sales Value, 2020-2031
6.8.2 Southeast Asia Stage 2 Infant Formula Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Stage 2 Infant Formula Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Stage 2 Infant Formula Sales Value, 2020-2031
6.9.2 India Stage 2 Infant Formula Sales Value by Type (%), 2024 VS 2031
6.9.3 India Stage 2 Infant Formula Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Mead Johnson
7.1.1 Mead Johnson Company Information
7.1.2 Mead Johnson Introduction and Business Overview
7.1.3 Mead Johnson Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Mead Johnson Stage 2 Infant Formula Product Offerings
7.1.5 Mead Johnson Recent Development
7.2 Nestle
7.2.1 Nestle Company Information
7.2.2 Nestle Introduction and Business Overview
7.2.3 Nestle Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Nestle Stage 2 Infant Formula Product Offerings
7.2.5 Nestle Recent Development
7.3 Danone
7.3.1 Danone Company Information
7.3.2 Danone Introduction and Business Overview
7.3.3 Danone Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Danone Stage 2 Infant Formula Product Offerings
7.3.5 Danone Recent Development
7.4 Abbott
7.4.1 Abbott Company Information
7.4.2 Abbott Introduction and Business Overview
7.4.3 Abbott Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Abbott Stage 2 Infant Formula Product Offerings
7.4.5 Abbott Recent Development
7.5 FrieslandCampina
7.5.1 FrieslandCampina Company Information
7.5.2 FrieslandCampina Introduction and Business Overview
7.5.3 FrieslandCampina Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 FrieslandCampina Stage 2 Infant Formula Product Offerings
7.5.5 FrieslandCampina Recent Development
7.6 Heinz
7.6.1 Heinz Company Information
7.6.2 Heinz Introduction and Business Overview
7.6.3 Heinz Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Heinz Stage 2 Infant Formula Product Offerings
7.6.5 Heinz Recent Development
7.7 Bellamy
7.7.1 Bellamy Company Information
7.7.2 Bellamy Introduction and Business Overview
7.7.3 Bellamy Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bellamy Stage 2 Infant Formula Product Offerings
7.7.5 Bellamy Recent Development
7.8 Topfer
7.8.1 Topfer Company Information
7.8.2 Topfer Introduction and Business Overview
7.8.3 Topfer Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Topfer Stage 2 Infant Formula Product Offerings
7.8.5 Topfer Recent Development
7.9 HiPP
7.9.1 HiPP Company Information
7.9.2 HiPP Introduction and Business Overview
7.9.3 HiPP Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 HiPP Stage 2 Infant Formula Product Offerings
7.9.5 HiPP Recent Development
7.10 Perrigo
7.10.1 Perrigo Company Information
7.10.2 Perrigo Introduction and Business Overview
7.10.3 Perrigo Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Perrigo Stage 2 Infant Formula Product Offerings
7.10.5 Perrigo Recent Development
7.11 Arla
7.11.1 Arla Company Information
7.11.2 Arla Introduction and Business Overview
7.11.3 Arla Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Arla Stage 2 Infant Formula Product Offerings
7.11.5 Arla Recent Development
7.12 Holle
7.12.1 Holle Company Information
7.12.2 Holle Introduction and Business Overview
7.12.3 Holle Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Holle Stage 2 Infant Formula Product Offerings
7.12.5 Holle Recent Development
7.13 Meiji
7.13.1 Meiji Company Information
7.13.2 Meiji Introduction and Business Overview
7.13.3 Meiji Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Meiji Stage 2 Infant Formula Product Offerings
7.13.5 Meiji Recent Development
7.14 Biostime
7.14.1 Biostime Company Information
7.14.2 Biostime Introduction and Business Overview
7.14.3 Biostime Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Biostime Stage 2 Infant Formula Product Offerings
7.14.5 Biostime Recent Development
7.15 China Feihe
7.15.1 China Feihe Company Information
7.15.2 China Feihe Introduction and Business Overview
7.15.3 China Feihe Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 China Feihe Stage 2 Infant Formula Product Offerings
7.15.5 China Feihe Recent Development
7.16 Junlebao Dairy
7.16.1 Junlebao Dairy Company Information
7.16.2 Junlebao Dairy Introduction and Business Overview
7.16.3 Junlebao Dairy Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Junlebao Dairy Stage 2 Infant Formula Product Offerings
7.16.5 Junlebao Dairy Recent Development
7.17 Ausnutria Dairy
7.17.1 Ausnutria Dairy Company Information
7.17.2 Ausnutria Dairy Introduction and Business Overview
7.17.3 Ausnutria Dairy Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Ausnutria Dairy Stage 2 Infant Formula Product Offerings
7.17.5 Ausnutria Dairy Recent Development
7.18 Yili Group
7.18.1 Yili Group Company Information
7.18.2 Yili Group Introduction and Business Overview
7.18.3 Yili Group Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Yili Group Stage 2 Infant Formula Product Offerings
7.18.5 Yili Group Recent Development
7.19 Synutra
7.19.1 Synutra Company Information
7.19.2 Synutra Introduction and Business Overview
7.19.3 Synutra Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Synutra Stage 2 Infant Formula Product Offerings
7.19.5 Synutra Recent Development
7.20 Beingmate
7.20.1 Beingmate Company Information
7.20.2 Beingmate Introduction and Business Overview
7.20.3 Beingmate Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Beingmate Stage 2 Infant Formula Product Offerings
7.20.5 Beingmate Recent Development
7.21 Yashili
7.21.1 Yashili Company Information
7.21.2 Yashili Introduction and Business Overview
7.21.3 Yashili Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Yashili Stage 2 Infant Formula Product Offerings
7.21.5 Yashili Recent Development
7.22 Bright Dairy
7.22.1 Bright Dairy Company Information
7.22.2 Bright Dairy Introduction and Business Overview
7.22.3 Bright Dairy Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 Bright Dairy Stage 2 Infant Formula Product Offerings
7.22.5 Bright Dairy Recent Development
8 Industry Chain Analysis
8.1 Stage 2 Infant Formula Industrial Chain
8.2 Stage 2 Infant Formula Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Stage 2 Infant Formula Sales Model
8.5.2 Sales Channel
8.5.3 Stage 2 Infant Formula Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Stage 2 Infant Formula market is projected to grow from US$ 21710 million in 2025 to US$ 33970 million by 2032, at a CAGR of 6.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 190
USD 4900.00
(Single User License)
The global Stage 2 Infant Formula market size was US$ 21710 million in 2025 and is forecast to reach a readjusted size of US$ 33970 million by 2032 with a CAGR of 6.7% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 114
USD 4250.00
(Single User License)
The global market for Stage 2 Infant Formula was estimated to be worth US$ 21710 million in 2025 and is projected to reach US$ 33970 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 154
USD 3950.00
(Single User License)
The global Stage 2 Infant Formula market was valued at US$ 21710 million in 2025 and is anticipated to reach US$ 33970 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 139
USD 2900.00
(Single User License)
The global Stage 2 Infant Formula market is projected to grow from US$ 20480 million in 2024 to US$ 32040 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 189
USD 4900.00
(Single User License)
The global Stage 2 Infant Formula market size was US$ 20480 million in 2024 and is forecast to a readjusted size of US$ 32040 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 113
USD 4250.00
(Single User License)
The global market for Stage 2 Infant Formula was valued at US$ 20480 million in the year 2024 and is projected to reach a revised size of US$ 32040 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-03-13
Pages: 110
USD 2900.00
(Single User License)
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published Date: 2024-09-01
Pages: 175
USD 4350.00
(Single User License)
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published Date: 2024-09-01
Pages: 112
USD 2900.00
(Single User License)
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published Date: 2024-09-01
Pages: 191
USD 4900.00
(Single User License)
The global Stage 2 Infant Formula market is projected to grow from US$ 21710 million in 2025 to US$ 33970 million by 2032, at a CAGR of 6.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 190
The global Stage 2 Infant Formula market size was US$ 21710 million in 2025 and is forecast to reach a readjusted size of US$ 33970 million by 2032 with a CAGR of 6.7% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 114
The global market for Stage 2 Infant Formula was estimated to be worth US$ 21710 million in 2025 and is projected to reach US$ 33970 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-01-09
Pages: 154
The global Stage 2 Infant Formula market was valued at US$ 21710 million in 2025 and is anticipated to reach US$ 33970 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-01-09
Pages: 139
The global Stage 2 Infant Formula market is projected to grow from US$ 20480 million in 2024 to US$ 32040 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 189
The global Stage 2 Infant Formula market size was US$ 20480 million in 2024 and is forecast to a readjusted size of US$ 32040 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 113
The global market for Stage 2 Infant Formula was valued at US$ 20480 million in the year 2024 and is projected to reach a revised size of US$ 32040 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-03-13
Pages: 110
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published: 2024-09-01
Pages: 175
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published: 2024-09-01
Pages: 112
Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
Published: 2024-09-01
Pages: 191
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now